Drug Safety Table 1

Drug Safety - Table 1

Table 1. Baseline laboratory monitoring for disease modifying anti-rheumatic drugs (DMARDs).

Drug	Hemoglobin or Hematocrit	WBC	Platelet Count	Serum Creatinine	AST or ALT	Albumin	Alkaline Phosphatase	CXR†	Chemistry Panel	Other
Hydroxychloroquine‡
Sulfasalazine	X	X	X		X	X				Urinary protein
Methotrexate	X	X	X	X	X	X	X	X
Leflunomide	X	X	X	X	X	X
Etanercept								X		PPD
Kineret								X		PPD
Infliximab								X		PPD
Adalimumab								X		PPD
Azathioprine	X	X	X	X	X	X
Intramuscular Gold	X	X	X	X						Urinary protein
Oral Gold	X	X	X							urinalysis
Cyclosporine	X	X	X	X	X	X				Uric acid and blood pressure
Oral glucocorticoids									X	Blood pressure DEXA scan§

*WBC = white blood cell count; AST = aspartate aminotransferase; ALT = alanine aminotransferase; CXR = chest radiograph; PPD = purified protein derivative standard; DEXA = dual-energy x-ray absorptiometry; † within previous year; ‡ no baseline monitoring; § within 6 months of initiating continuous therapy at an average dose of 7.5 mg/day.

Back to Drug Safety QPI